After ovarian cancer surgery, Mary Barbera spent three months in rehab before finally returning home, a milestone that marked ...

The FDA granted breakthrough therapy designation to first-line treatment with Enhertu plus Perjeta for unresectable or metastatic HER2+ breast cancer.

Cancer leaves deep emotional scars long after treatment ends, but for many survivors, honest, unfiltered writing can be a ...

Dr. Ma discussed key findings that have been shared so far this year on the topic of evolving treatment strategies for ...

SH-110, a liquid cancer treatment for glioma, earned orphan drug status from the FDA, helping patients who struggle to ...

Terry Gillespie said the hardest parts of her cancer journey were the isolation, the impact of chemotherapy, and how ...

A watercolor set gifted during my bone marrow transplant for acute myeloid leukemia became my outlet for wonder, creativity, ...

Panelists discuss how preparing multiple myeloma patients for treatment involves structured education, emotional support, and proactive symptom management—emphasizing clear communication about the ...

Panelists discuss how treatment decisions in multiple myeloma are guided by disease risk, patient health, and evolving ...

Panelists discuss the emotional and diagnostic journey of a multiple myeloma patient and his care partner, highlighting how incidental back pain led to an unexpected cancer diagnosis, the initial ...

Panelists highlight that being a care partner is one of the most challenging roles, requiring emotional resilience, ...

Dr. Erika Hamilton says social media and professional guidelines help patients stay informed about fast-changing breast cancer treatments and advances.